Status:
UNKNOWN
Auriculotherapy for Intraoperative Blood Pressure Control
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Nasal Polyps
Anesthesia
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
The endoscopic surgery of the paranasal sinuses (FESS) requires careful control of arterial pressure to prevent bleeding of the nasal mucosa that may lead to a reduction in the visual field. However, ...
Eligibility Criteria
Inclusion
- Patients of both sexes to undergo Functional Endoscopic Sinus Surgery (FESS) under General Anesthesia
- Patients aged between 18 and 69 years
- History of well-controlled essential hypertension under pharmacological treatment for at least one year
- ASA Class II-III.
Exclusion
- Age \< 18 years;
- Pregnancy status;
- NYHA class \> III;
- ASA class \> III;
- BMI \> 35;
- Positive history of Myocardial Infarction or neurovascular diseases;
- Previous treatment with antineoplastic agents;
- Secondary hypertension;
- Uncontrolled hypertension despite therapy (MAP \> 125 in preoperative visit);
- Anatomic alterations of the auricles;
- Presence of carotid stenosis \> 50%;
- Allergy or intolerance to drugs specified in the clinical protocol;
- Nickel or metal allergy present in magnetic spheres;
- Refusal of informed consent or inability to express it
Key Trial Info
Start Date :
June 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06182982
Start Date
June 15 2024
End Date
July 30 2024
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Gemelli IRCCS
Rome, Italy, 00168